Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Apixaban 5 mg Tablet versus Eliquis in Healthy Thai Volunteers under Fasting
TCTR20240715013Phase 1Unknown
- Sponsor
- Bio-innova
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of apixaban in venous thromboembolism (VTE), Atrial fibrillation (AFib) and pulmonary embolism (PE) (2 arms), sponsored by Bio-innova. Status: unknown.
02
Drugs
apixaban
03
Conditions
venous thromboembolism (VTE)Atrial fibrillation (AFib)pulmonary embolism (PE)
Beyond the preview
Go deeper on TCTR20240715013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240715013.